Amgen discloses more than $400 million stake in recent IPO Neumora Therapeutics
September 27, 2023 at 08:36 AM EDT
An Amgen disclosure of a large stake in Neumora Therapeutics indicated the value of its investment in the biotech, which recently went public, has tripled.
